Hepatocellular Adenocarcinoma
1 clinical trials · Condition
◉ Watch Hepatocellular Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies (NCT02638909) | Criterium, Inc. | 2015-12-01 |
Track Hepatocellular Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.